Serum total and free prostate-specific antigen for breast cancer diagnosis in women

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 467-473

  Black, Margot H ^a   Giai, Maurizia ^b   Ponzone, Riccardo ^b   Sismondi, Piero ^b   Yu, He ^c   Diamandis, Eleftherios P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TURIN   (Italy)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BREAST CANCER; BREAST CYST; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERUS MYOMA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROCYSTIC BREAST DISEASE; FOLLOW-UP STUDIES; HUMANS; LEIOMYOMA; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UTERINE NEOPLASMS;

EID: 0033970144     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Wang, M. C., Papsidero, L. C., Kuriyama, M., Valenzuela, L. A., Murphy, G. P., and Chu, T. M. Prostate antigen: a new potential marker for prostatic cancer. Prostate, 2: 89-96, 1981.
2. Lilja, H., Oldbring, J., Rannevik, G., and Laurell, C. B. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J. Clin. Investig., 80: 281-285, 1987.
3. Lilja, H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Investig., 76: 1899-1903, 1985.
4. Diamandis, E. P., and Yu, H. Nonprostatic sources of prostate-specific antigen. Urol. Clin. N. Am., 24: 275-282, 1997.
5. Pollen, J. J., and Dreilinger, A. Immunohistochemical identification of prostatic acid phosphatase and prostate specific antigen in female periurethral glands. Urology, 23: 303-304, 1984.
6. Tepper, S. L., Jagirdar, J., Heath, D., and Geller, S. A. Homology between the female paraurethral (Skene's) glands and the prostate. Immuno-histochemical demonstration. Arch. Pathol. Lab. Med., 108: 423-425, 1984.
7. Yu, H., Diamandis, E. P., Levesque, M., Giai, M., Roagna, R., Ponzone, R., Sismondi, P., Monne, M., and Croce, C. M. Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res. Treat., 40: 171-178, 1996.
8. Diamandis, E. P., Yu, H., and Sutherland, D. J. A. Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res. Treat., 32: 301-310, 1994.
9. Yu, H., Diamandis, E. P., and Sutherland, D. J. A. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin. Biochem., 27: 75-79, 1994.
10. Yu, H., Giai, M., Diamandis, E. P., Katsaros, D., Sutherland, D. J. A., Levesque, M. A., Roagna, R., Ponzone, R., and Sismondi, P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res., 55: 2104-2110, 1995.
11. Diamandis, E. P., Yu, H., and Lopez-Otin, C. Prostate specific antigen: a new constituent of breast cyst fluid. Breast Cancer Res. Treat., 38:259-264, 1996.
12. Mannello, F., Bocchiotti, G., Bianchi, G., Marcheggiani, F., and Gazzanelli, G. Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids. Breast Cancer Res. Treat., 38: 247-252, 1996.
13. Yu, H., and Diamandis, E. P. Prostate-specific antigen in milk of lactating women. Clin. Chem., 41: 54-58, 1995.
14. Sauter, E. R., Daly, M., Lenahan, K., Ehya, H., Engstrom, P. F., Sorling, A., Bonney, G., Yu, H., and Diamandis, E. P. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol. Biomark. Prev., 5: 967-970. 1996.
15. Foretova, L., Garber, J. E., Sadowski, N. L., Verselis, S. J., and Li, F. P. Prostate-specific antigen in nipple aspirate. Lancet, 347: 1631, 1996.
16. Sauter, E. R., Babb, J., Daly, M., Engstrom, P. F., Ehya, H., Malick, J., and Diamandis, E. P. Prostate-specific antigen production in the female breast: association with progesterone. Cancer Epidemiol. Biomark. Prev., 7: 315-320, 1998.
17. Monne, M., Croce, C. M., and Diamandis, E. P. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res., 54: 6344-6347, 1994.
18. Yu, H., Diamandis, E. P., Zarghami, N., and Grass, L. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res. Treat., 32: 291-300, 1994.
19. Zarghami, N., Grass, L., and Diamandis, E. P. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br. J. Cancer, 75: 579-588, 1997.
20. Kuriyama, M., Wang, M. C., Papsidero, L. D., Killian, C. S., Shimano, T., Valenzuela, L., Nishiura, T., Murphy, G. P., and Chu, T. M. Quantification of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res., 40: 4568-4662, 1980.
21. 1-antichymotrypsin. Clin. Chem., 37: 1618-1625, 1991.
22. Armbruster, D. A. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin. Chem., 39: 181-195, 1993.
23. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222-226, 1991.
24. Woodrum, D. L., Brawer, M. K., Partin, A. W., Catalona, W. J., and Southwick, P. C. Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J. Urol., 159: 5-12, 1998.
25. Yu, H., and Diamandis, E. P. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J. Urol., 153: 1004-1008, 1995.
26. Melegos, D. M., and Diamandis, E. P. Is prostate-specific antigen present in female serum? Clin. Chem., 44: 691-692, 1998.
27. Giai, M., Yu, H., Roagna, R., Ponzone, R., Katsaros, D., Levesque, M. A., and Diamandis, E. P. Prostate-specific antigen in serum of women with breast cancer. Br. J. Cancer, 72: 728-731, 1995.
28. Melegos, D. N., and Diamandis, E. P. Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer. Clin. Biochem., 29: 193-200, 1996.
29. Borchert, G. H., Melegos, D. N., Tomlinson, G., Giai, M., Roagna, M., Ponzone, R., Sgro, L., and Diamandis, E. P. Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases. Br. J. Cancer, 16: 1087-1094, 1997.
30. Ferguson, R. A., Yu, H., Kalyvas, M., Zammit, S., and Diamandis, E. P. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite® immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin. Chem., 42: 675-684, 1996.
31. Black, M. H., Grass, C. L., Leinonen, J., Stenman, U-H., and Diamandis, E. P. Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays. Clin. Chem., 45: 347-354, 1999.
32. Bloom, H. J. G., and Richardson, W. W. Histological grading and prognosis in breast cancer. Br. J. Cancer, 11: 359-377, 1957.
33. Christopoulos, T. K., and Diamandis, E. P. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal. Chem., 64: 342-346, 1992.
34. Oesterling, J. E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907-923, 1991.
35. Akdas, A., Cevik, I., Tarcan, T., Turkeri, L., Dalaman, G., and Emerk, K. The role of free prostate-specific antigen in the diagnosis of prostate cancer. Br. J. Urol., 79: 920-923, 1997.
36. Forbes, J. F. The incidence of breast cancer: the global burden, public health considerations. Semin. Oncol., 24: S120-S135, 1997.
37. Morrison, A. S. Screening for cancer of the breast. Epidemiol. Rev., 15: 244-255, 1993.
38. Ferguson, J. H. National Institutes of Health consensus development conference statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J. Natl. Cancer Inst., 89: 1015-1020, 1997.
39. Devine, P. L., Duroux ,M. A., Quin, R. J., McGuckin, M. A., Joy, G. J., Ward, B. G., and Pollard, C. W. CA 15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer. Breast Cancer Res. Treat., 34: 245-251, 1995.
40. Eskelinen, M., Kataja, V., Hamalainen, E., Kosma, V. M., Penttila, I., and Alhava, E. Serum tumour markers CEA, AFP, CA 15-3, TPS, and Neu in diagnosis of breast cancer. Anticancer Res., 17: 1231-1234, 1997.
41. Heinze, T., Schurenkamper, P., Minguillon, C., and Lichtenegger, W. Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors. Anticancer Res., 17: 2953-2954, 1997.
42. Killian, C. S., Corral, D. A., Kawinski, E., and Constantine, R. I. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptors. Biochem. Biophys. Res. Commun., 192: 940-947, 1993.
43. Webber, M. M., Waghray, A., and Bello, D. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin. Cancer Res., 1: 1089-1094, 1995.
44. Cohen, P., Graves, H. C. B., Peehl, D. M., Kamerei, M., Giudice, L. C., and Rosenfeld, R. G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab., 75: 1046-1053, 1992.
45. Cohen, P., Peehl, D. M., Graves, H. C. B., and Rosenfeld, R. G. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocrinol., 142: 407-415, 1994.
46. Oh, Y., Muller, H. L., Lamson, G., and Rosenfeld, R. G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J. Biol. Chem., 268: 14964-14971, 1993.
47. Oh, Y., Gucev, Z., Ng, L., Muller, H. L., and Rosenfeld, R. G. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 on human breast cancer cells. Prog. Growth Factor Res., 6: 503-512, 1995.
48. Gill, Z. P., Perks, C. M., Newcomb, P. V., and Holly, J. M. P. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J. Biol. Chem., 272: 25602-25607, 1997.